SCHEMBL4475745

SCHEMBL4475745

COc1cc(/C=C/C=C(\C#N)C(=O)NCc2ccc(O)c(O)c2)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.68
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 2/20 0.54
MAPT P10636 2/20 0.54
MCL1 Q07820 1/20 0.53
EGFR P00533 4/20 0.53
ERBB2 P04626 2/20 0.53
DNM1 Q05193 1/20 0.53
TYR P14679 1/20 0.53
ACHE P22303 1/20 0.53
NSD2 O96028 1/20 0.51
IDE P14735 1/20 0.51
EEF2K O00418 1/20 0.50
PLK4 O00444 1/20 0.50
PIM1 P11309 1/20 0.50
AXL P30530 1/20 0.50
MAPKAPK2 P49137 1/20 0.50
GSK3A P49840 1/20 0.50
GSK3B P49841 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4475751 1.00 MAOB (0.68) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL3437189 0.96 MAOB (0.63) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL13678173 0.93 MAOB (0.59) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL4484526 0.92 MAOB (0.62) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL4484516 0.92 MAOB (0.62) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL13678171 0.91 MAOB (0.59) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL4487377 0.91 MAOB (0.70) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL13678107 0.91 MAOB (0.64) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL4487372 0.91 MAOB (0.70) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL4477433 0.90 MAOB (0.77) MAOBMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA MAOB 3511/4885MEN1 2749/4885KMT2A 3146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.